Comment

. 2019 Aug 1;37(22):1984-1985.

doi: 10.1200/JCO.19.00932. Epub 2019 Jun 18.

Reply to C.L. Braal et al, H. Brauch et al, and M.P. Goetz et al

Henk-Jan Guchelaar¹, Anabel Sanchez-Spitman¹, Vincent Dezentjé¹, Stefan Böhringer¹, Jesse Swen¹, Patrick Neven¹, Hans Gelderblom¹

Affiliations

Affiliation

¹ Henk-Jan Guchelaar, PharmD, PhD and Anabel Sanchez-Spitman, PharmD, Leiden University Medical Center, Leiden, the Netherlands; Vincent Dezentjé, MD, PhD, Netherlands Cancer Institute/Antoni van Leeuwenhoek, Amsterdam, the Netherlands; Stefan Böhringer, PhD, MD and Jesse Swen, PharmD, PhD, Leiden University Medical Center, Leiden, the Netherlands; Patrick Neven, MD, PhD, University Hospitals Leuven, Leuven, Belgium; and Hans Gelderblom, MD, PhD, Leiden University Medical Center, Leiden, the Netherlands.

PMID: 31211601
DOI: 10.1200/JCO.19.00932

Comment

Reply to C.L. Braal et al, H. Brauch et al, and M.P. Goetz et al

Henk-Jan Guchelaar et al. J Clin Oncol. 2019.

. 2019 Aug 1;37(22):1984-1985.

doi: 10.1200/JCO.19.00932. Epub 2019 Jun 18.

Authors

Henk-Jan Guchelaar¹, Anabel Sanchez-Spitman¹, Vincent Dezentjé¹, Stefan Böhringer¹, Jesse Swen¹, Patrick Neven¹, Hans Gelderblom¹

Affiliation

¹ Henk-Jan Guchelaar, PharmD, PhD and Anabel Sanchez-Spitman, PharmD, Leiden University Medical Center, Leiden, the Netherlands; Vincent Dezentjé, MD, PhD, Netherlands Cancer Institute/Antoni van Leeuwenhoek, Amsterdam, the Netherlands; Stefan Böhringer, PhD, MD and Jesse Swen, PharmD, PhD, Leiden University Medical Center, Leiden, the Netherlands; Patrick Neven, MD, PhD, University Hospitals Leuven, Leuven, Belgium; and Hans Gelderblom, MD, PhD, Leiden University Medical Center, Leiden, the Netherlands.

PMID: 31211601
DOI: 10.1200/JCO.19.00932

No abstract available

PubMed Disclaimer

Comment on

Tamoxifen Pharmacogenetics and Metabolism: Results From the Prospective CYPTAM Study.
Sanchez-Spitman A, Dezentjé V, Swen J, Moes DJAR, Böhringer S, Batman E, van Druten E, Smorenburg C, van Bochove A, Zeillemaker A, Jongen L, Los M, Neven P, Gelderblom H, Guchelaar HJ. Sanchez-Spitman A, et al. J Clin Oncol. 2019 Mar 10;37(8):636-646. doi: 10.1200/JCO.18.00307. Epub 2019 Jan 24. J Clin Oncol. 2019. PMID: 30676859
Tamoxifen Pharmacogenetics and Metabolism: The Same Is Not the Same.
Brauch H, Schroth W, Mürdter T, Schwab M. Brauch H, et al. J Clin Oncol. 2019 Aug 1;37(22):1981-1982. doi: 10.1200/JCO.19.00507. Epub 2019 Jun 18. J Clin Oncol. 2019. PMID: 31211600 No abstract available.
Tamoxifen Metabolism and Breast Cancer Recurrence: A Question Unanswered by CYPTAM.
Goetz MP, Suman VJ, Nakamura Y, Kiyotani K, Jordan VC, Ingle JN. Goetz MP, et al. J Clin Oncol. 2019 Aug 1;37(22):1982-1983. doi: 10.1200/JCO.19.00504. Epub 2019 Jun 18. J Clin Oncol. 2019. PMID: 31211604 Free PMC article. No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Reply to C.L. Braal et al, H. Brauch et al, and M.P. Goetz et al

Affiliation

Reply to C.L. Braal et al, H. Brauch et al, and M.P. Goetz et al

Authors

Affiliation

Comment on

Similar articles

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Comment on

Similar articles

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources